Antimicrobial agents. are chemicals active against microorganisms

Similar documents
Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Antimicrobials & Resistance

Antimicrobial Therapy

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Principles of Antimicrobial therapy

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to antimicrobial agents

Antimicrobial agents

Antibiotic Resistance in Bacteria

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R

WHY IS THIS IMPORTANT?

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Antimicrobial chemotherapy - history - principles and practice - mode of action, resistance. Dr. Berek Zsuzsa. 01 October 2013

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Antibiotics & Resistance

An#bio#cs and challenges in the wake of superbugs

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

bacteria fungi HOW? WHAT? protozoa virus Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Antibacterial susceptibility testing

Antimicrobials. Antimicrobials

Microbiology ( Bacteriology) sheet # 7

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Chapter 51. Clinical Use of Antimicrobial Agents

Mechanism of antibiotic resistance

Phar 754: Antimicrobial Agents

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Protein Synthesis Inhibitors

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.

CSLO3. Distinguish between mechanisms of physical and chemical agents to control microbial populations.

Classification of antimicrobial agents:

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

control microbial growth in vivo

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Appropriate Antimicrobial Therapy for Treatment of

LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health

Antimicrobial Resistance and Prescribing

بسم هللا الرحمن الرحيم

ICAAC. Key words: antibacterial agent development approval. linezolid β. chloramphenicol tetracycline colistin mupirocin teicoplanin

Antimicrobial use in poultry: Emerging public health problem

Is erythromycin bactericidal

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

ANTIBIOTICS IN PLASMA

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Chemotherapeutic Agents

دکتر فرينبز راشذ مرنذی متخصص آسيب شنبسی تشريحی و ببلينی عضو هيئت علمی آزمبيشگبه مرجع سالمت

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

The new antistaphylococcal drugs (tigecycline, daptomycin, telavancin, ): is the future (really) shining?

Other Beta - lactam Antibiotics

Introduction to Antimicrobial Therapy

ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Antibacterial Agents & Conditions. Stijn van der Veen

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

Antimicrobial Resistance

Medicinal Chemistry of Modern Antibiotics

Mechanisms and Pathways of AMR in the environment

Controlling microbial growth in vivo by using antimicrobial agents. Dr. Nasser M. Kaplan Medical Microbiology JUST, Irbid, Jordan

General Approach to Infectious Diseases

Introduction to Antimicrobial Therapy

Management of Antibiotic Resistant Pathogens

ANTIMICROBIAL RESISTANCE: An Overview

Antimicrobial Therapy

Should we test Clostridium difficile for antimicrobial resistance? by author

Medicinal Chemistry of Modern Antibiotics

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Multi-drug resistant microorganisms

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Curricular Components for Infectious Diseases EPA

Search for Antimicrobial Agents Produced by the Soil Actinomycetes

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

So to begin, I am going to brief you on the history of antibiotics. As you know, bacteria

بسم هللا الرحمن الرحيم

Overview of antibiotic combination issues.

Introduction to Antimicrobial Therapy

January 2014 Vol. 34 No. 1

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Introduction to Pharmacokinetics and Pharmacodynamics

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

The Aftermath of Penicillin

Transcription:

Antimicrobial agents are chemicals active against microorganisms

Antibacterial Agents Are chemicals active against bacteria

Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan -anti-helmintic

Antibacterials include Antibiotics Semisentehetic antibacterials Synthetic(sulfonamids,quinolones)

Antibiotic is the natural products of fungi and bacteria that kill or inhibit the growth of microorganisms

Selective toxicity: Was described by immunochemist Paul Ehrlich.

Selective toxicity Ideally the antimicrobial agent should act at a target side Present in the infecting organism But absent from host cell

Selective toxicity:proposed by Paul Ehrlich(1854-1915)

Selective toxicity is more likely achievable in microorganisms which are procaryotes (bacteria) than those that are eucaryotes(fungi) because procaryotes are structurally more distinct from host cells which is eucaryotic

Classification of antibacterials According to whether they are bactericidal or bacteriostatic By target site(mechanisms of action) By chemical structure

Bactericidal antibacterials kill bacteria irreversible more effective in immunocompromised patienst

Bacterostatic antibacterials They only inhibit the growth of bacteria It is reversable They prevent the bacterial population from increasing Host defense mechanism can consequently cope with the static population

Some agents are capable of killing some bacteria And only bacteriostatic for others

1935:chemotherapy of systemic bacterial infections. Although antiseptics had been applied topically to prevent the growth of microorganisms, the existing antiseptics were ineffective against systemic bacterial infections. In 1935, the dye prontosil was shown to protect mice against systemic streptococcal infection and to be curative in patients suffering from such infections. It was soon found that prontosil was cleaved in the body to release p-aminobenzene sulfonamide (sulfanilamide), which was shown to have antibacterial activity. This first "sulfa" drug ushered in a new era in medicine.

Compounds produced by microorganisms (antibiotics) were eventually discovered to inhibit the growth of other microorganisms. For example, Alexander Fleming was the first to realize the mold Penicillium prevented the multiplication of staphylococci. A concentrate from a culture of this mold was prepared, and the remarkable antibacterial activity and lack of toxicity of the first antibiotic, penicillin, were demonstrated. Streptomycin and the tetracyclines were developed in the 1940s and 1950s, followed rapidly by the development of additional aminoglycosides, semisynthetic penicillins, cephalosporins, quinolones, and other antimicrobials. All these antibacterial agents greatly increased the range of infectious diseases that could be prevented or cured.

Although the development of new antibacterial antibiotics has lagged in recent years, some new classes of agents have been introduced, including the ketolides (e.g., telithromycin), glycylcyclines (tigecycline), lipopeptides (daptomycin), streptogramins (quinupristin-dalfopristin), and oxazolidinones (linezolid).

Unfortunately, with the introduction of new chemotherapeutic agents, bacteria have shown a remarkable ability to develop resistance. Thus antibiotic therapy will not be the magical cure for all infections, as predicted; rather, it is only one weapon, albeit an important one, against infectious diseases. It is also important to recognize that because resistance to antibiotics is often not predictable, physicians must rely on their clinical experience for the initial selection of empirical therapy. Guidelines for the management of infections caused by specific organisms are discussed.

Antibacterial Agents Mechanisms of action Antibacterial spectrum Common mechanisms of resistance

The five main target sites for antibacterial action are: Cell wall synthesis Protein synthesis Nucleic acid synthesis Methabolic pathways Cell membrane function

Classification according to mechanisms of action Inhibitors of cell wall synthesis Inhibitors of protein synthesis Inhibitors of nucleic acid synthesis Antimetabolites Inhibitors of cytoplasmic membrane function

Antibacterial spectrum Range of activity of an antimicrobial against bacteria Broad spectrum: inhibits a wide variety of gram-positive and gram-negative bacteria Narrow spectrum: active against a limited variety of bacteria : Vancomycin

Antibiotic combinations To broaden the spectrum for empirical therapy or treatment of polymicrobial infections To prevent the emergence of resistant microorganisms To achieve a synergistic killing effect

Antibiotic combinations A good example is the treatment of tuberculosis

Antibiotic synergism: Antibiotic antagonism:

A)Synergism B)Antagonism

Antibacterial agents Sulfonamide Penicillin (Flemming) Streptomycin Tetracyclin...and many others

Despite the rapidity of the introduction of new chemotherapeutics Development of resistance!!!

In vitro antimicrobial susceptibility testing Selects the active chemotherapeutic agent

Susceptibility tests Disc diffusion Dilution tests

Disc diffusion

Disc diffusion test result

Dilution test

Resistance 1-Genetic bases of resistance 2-Biochemical mechanism of resistance

1-Genetic basis of resistance Mutation of cellular genes Acquisition of resistance genes Mutation of acquired genes

Biochemical mechanism of resistance Modification of the antibiotic: such as betalactamases Modification of the target molecule Restricted access to the target Efflux pumps